| Preview | Issue Date | Title / Name | Author(s) | Type |
| 2014 | A new hand enhances life for quadruple amputee: A single case study | Anjou, K.; Gibbs, J.; Purtell, D.; Morrison, W. | Journal Article | |
| 2022 | CDK4/6 Inhibitors (CKD4/6i) in advanced hormone-receptor-positive (HR+) HER2-negative (HER2-) breast cancer: Prescribing practices and outcomes in a real-world, Australian cohort | Javaid, Anadil; Lok, Sheau Wen; Wong, Vanessa; Baron-Hay, Sally; Boyle, Fran, et al | Conference Paper | |
| 2019 | Clinical impact of tissue of origin testing and mutation profiling in the Solving Unknown Primary Cancer (SUPER) national prospective study: Experience of the first two years | Mileshkin, Linda R.; Sivakumaran, Tharani; Etemadmoghadam, Dariush; Tothill, Richard; Fellowes, Andrew, et al | Conference Paper | |
| 2020 | Real world outcomes in elderly patients with HER2 positive advanced breast cancer | Evans, Nicole; Anton, Angelyn; Wong, Rachel; Lok, Sheau Wen; De Boer, Richard, et al | Conference Paper | |
| 2021 | Real world outcomes in elderly women with HER2 positive advanced breast cancer | Evans, Nicole; Anton, Angelyn; Wong, Rachel; Lok, Sheau Wen; De Boer, Richard, et al | Conference Paper | |
 | 2020 | Real World Outcomes in Elderly Women with HER2-Positive Advanced Breast Cancer | Evans, Nicole; Anton, Angelyn; Wong, Rachel; Lok, Sheau Wen; De Boer, Richard, et al | Conference Paper | |
| 2021 | Real-world outcomes in patients with brain metastases secondary to HER2-positive breast cancer: An Australian multi-centre registry-based study | Tung, Iris; Moldovan, Cristina; Wong, Vanessa; De Boer, Richard; Gibbs, Peter, et al | Conference Paper | |
| 2020 | Real-world uptake of bone modifying agents in advanced breast cancer with bone metastases-Prospective data from a multi-site Australian registry | Wong, Vanessa; De Boer, Richard; Anton, Angelyn; Malik, Laeeq; Greenberg, Sally, et al | Conference Paper | |
